{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:18:16Z","timestamp":1773933496155,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014269","name":"Uniwersytet Medyczny w Bia\u0142ymstoku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006445","name":"Uniwersytet Warszawski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118929","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-inflammatory effects of ceragenin CSA-13 in acute pyelonephritis -insights from an animal model"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-3475","authenticated-orcid":false,"given":"Urszula","family":"Wnorowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewelina","family":"Piktel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118929_bib1","article-title":"Disease burden and long-term trends of urinary tract infections: a worldwide report","volume":"10","author":"Yang","year":"2022","journal-title":"Front. Public Health"},{"issue":"6","key":"10.1016\/j.biopha.2025.118929_bib2","first-page":"1407","article-title":"Genetic factors that contribute to antibiotic resistance through intrinsic and acquired bacterial genes in urinary tract infections","volume":"11","author":"Harris","year":"2023","journal-title":"PubMed PMID"},{"issue":"5","key":"10.1016\/j.biopha.2025.118929_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/cit284","article-title":"Urinary tract infections: current and emerging management strategies","volume":"57","author":"Barber","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dkt301","article-title":"Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09","volume":"69","author":"Shapiro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12040623","article-title":"Urinary tract infections: the current scenario and future prospects","volume":"12","author":"Mancuso","year":"2023","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.biopha.2025.118929_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib7","first-page":"48","article-title":"Acute pyelonephritis in adults","volume":"378","author":"Johnson","year":"2018"},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/0886022X.2019.1591995","article-title":"Incidence, risk factors, and clinical outcomes of acute kidney injury associated with acute pyelonephritis in patients attending a tertiary care referral center","volume":"41","author":"Jeon","year":"2019","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0147-9571(03)00011-0","article-title":"Prevention of tissue injury in an ascending mouse model of chronic pyelonephritis--role of free radical scavengers","volume":"27","author":"Gupta","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"33","key":"10.1016\/j.biopha.2025.118929_bib10","doi-asserted-by":"crossref","first-page":"E3100","DOI":"10.1073\/pnas.1307096110","article-title":"Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection","volume":"110","author":"Plotnikov","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biopha.2025.118929_bib11","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)69004-0","article-title":"Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats","volume":"161","author":"Bennett","year":"1999","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118929_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2279-042X.179567","article-title":"Use of antioxidants in urinary tract infection","volume":"5","author":"Allameh","year":"2016","journal-title":"J. Res. Pharm. Pract."},{"issue":"7","key":"10.1016\/j.biopha.2025.118929_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70268","article-title":"Oxidative stress: signaling pathways, biological functions, and disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib14","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5603","article-title":"Role of the TGF\u2011\u03b2\/Smad signaling pathway in the transition from acute kidney injury to chronic kidney disease (Review)","volume":"56","author":"Zou","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0022-5347(17)35187-X","article-title":"Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats","volume":"151","author":"Haraoka","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2025.118929_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/134940","article-title":"Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis","volume":"2014","author":"Bahat \u00d6zdo\u011fan","year":"2014","journal-title":"Biomed. Res Int"},{"issue":"11","key":"10.1016\/j.biopha.2025.118929_bib17","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1007\/s00467-021-05117-5","article-title":"Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size","volume":"36","author":"Da Dalt","year":"2021","journal-title":"Pediatr. Nephrol. (Berl. Ger. )"},{"issue":"9","key":"10.1016\/j.biopha.2025.118929_bib18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00467-021-05398-w","article-title":"Dexamethasone to prevent kidney scarring in acute pyelonephritis: a randomized clinical trial","volume":"37","author":"Rius-Gordillo","year":"2022","journal-title":"Pediatr. Nephrol. (Berl. Ger. )"},{"issue":"11","key":"10.1016\/j.biopha.2025.118929_bib19","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00467-020-04622-3","article-title":"Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial","volume":"35","author":"Shaikh","year":"2020","journal-title":"Pediatr. Nephrol. (Berl. Ger. )"},{"issue":"6","key":"10.1016\/j.biopha.2025.118929_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jcyt.2013.02.003","article-title":"Inflammatory pre-conditioning of mesenchymal multipotent stromal cells improves their immunomodulatory potency in acute pyelonephritis in rats","volume":"15","author":"Plotnikov","year":"2013","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.biopha.2025.118929_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acs.bioconjchem.0c00642","article-title":"Recent progress in bile acid-based antimicrobials","volume":"32","author":"Lin","year":"2021","journal-title":"Bioconjugate Chem."},{"issue":"20","key":"10.1016\/j.biopha.2025.118929_bib22","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1021\/ol048845t","article-title":"Synthesis and characterization of peptide\u2212cationic steroid antibiotic conjugates","volume":"6","author":"Ding","year":"2004","journal-title":"Org. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"issue":"9","key":"10.1016\/j.biopha.2025.118929_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10091792","article-title":"Bile acids: major regulator of the gut microbiome","volume":"10","author":"An","year":"2022","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.biopha.2025.118929_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.biopha.2025.118929_bib26","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23281-y","article-title":"Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection","volume":"12","author":"Wnorowska","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2025.118929_bib28","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/jac\/dks276","article-title":"In vitro evaluation of the potential for resistance development to ceragenin CSA-13","volume":"67","author":"Pollard","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118929_bib29","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.2147\/IDR.S338827","article-title":"New \u03b2-Lactam antibiotics and ceragenins - a study to assess their potential in treatment of infections caused by multidrug-resistant strains of Pseudomonas aeruginosa","volume":"14","author":"Paprocka","year":"2021","journal-title":"Infect. Drug Resist"},{"issue":"7","key":"10.1016\/j.biopha.2025.118929_bib30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/2211-5463.12235","article-title":"Antimicrobial ceragenins inhibit biofilms and affect mammalian cell viability and migration in vitro","volume":"7","author":"Olekson","year":"2017","journal-title":"FEBS Open Bio"},{"issue":"7","key":"10.1016\/j.biopha.2025.118929_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101037","article-title":"In vitro bactericidal and bacteriolytic activity of ceragenin CSA-13 against planktonic cultures and biofilms of Streptococcus pneumoniae and other pathogenic streptococci","volume":"9","author":"Moscoso","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2025.118929_bib32","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1128\/AAC.00653-15","article-title":"Bactericidal activity of Ceragenin CSA-13 in cell culture and in an animal model of peritoneal infection","volume":"59","author":"Bucki","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2025.118929_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/dkm218","article-title":"Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum","volume":"60","author":"Bucki","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"18","key":"10.1016\/j.biopha.2025.118929_bib34","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1021\/ol0062704","article-title":"Preparation and characterization of cholic acid-derived antimicrobial agents with controlled stabilities","volume":"2","author":"Guan","year":"2000","journal-title":"Org. Lett."},{"issue":"16","key":"10.1016\/j.biopha.2025.118929_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.21037\/atm-21-3325","article-title":"Adiponectin alleviated renal cell apoptosis and inflammation via inactivation of JAK2\/STAT3 signal pathway in an acute pyelonephritis mouse model","volume":"9","author":"Dai","year":"2021","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.biopha.2025.118929_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2015.07.004","article-title":"Hydrogen peroxide signals E. coli phagocytosis by human polymorphonuclear cells; up-stream and down-stream pathway","volume":"6","author":"Petropoulos","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118929_bib37","article-title":"Innate lymphoid cells in renal inflammation","volume":"11","author":"Becker","year":"2020"},{"issue":"7","key":"10.1016\/j.biopha.2025.118929_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104660","article-title":"Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence","volume":"25","author":"Riding","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118929_bib39","doi-asserted-by":"crossref","unstructured":"Huang J., Fu L., Huang J., Zhao J., Zhang X., Wang W., et al. Group 3 Innate Lymphoid Cells Protect the Host from the Uropathogenic Escherichia coli Infection in the Bladder. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022;9(6):e2103303. Epub 2022\/01\/13. doi: 10.1002\/advs.202103303. PubMed PMID: 35018740; PubMed Central PMCID: PMCPMC8867143.","DOI":"10.1002\/advs.202103303"},{"key":"10.1016\/j.biopha.2025.118929_bib40","doi-asserted-by":"crossref","unstructured":"Cheung K.C.P., Ma J., Loiola R.A., Chen X., Jia W. Bile acid-activated receptors in innate and adaptive immunity: targeted drugs and biological agents. European journal of immunology, 2023;53(8):e2250299. Epub 2023\/05\/13. doi: 10.1002\/eji.202250299. PubMed PMID: 37172599.","DOI":"10.1002\/eji.202250299"},{"key":"10.1016\/j.biopha.2025.118929_bib41","doi-asserted-by":"crossref","unstructured":"Kumar R., Theiss A.L., Venuprasad K. ROR\u03b3t protein modifications and IL-17-mediated inflammation. Trends in immunology, 2021;42(11):1037-1050. Epub 2021\/10\/13. doi: 10.1016\/j.it.2021.09.005. PubMed PMID: 34635393; PubMed Central PMCID: PMCPMC8556362.","DOI":"10.1016\/j.it.2021.09.005"},{"issue":"11","key":"10.1016\/j.biopha.2025.118929_bib42","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4049\/jimmunol.1801042","article-title":"IL-17 in renal immunity and autoimmunity","volume":"201","author":"Biswas","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118929_bib43","first-page":"35","article-title":"Kidney-specific interleukin-17 responses during infection and injury","volume":"42","author":"Peroumal","year":"2024"},{"key":"10.1016\/j.biopha.2025.118929_bib44","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118929_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/IAI.72.1.82-88.2004","article-title":"Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation","volume":"72","author":"Chromek","year":"2004","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5152\/tud.2017.06337","article-title":"Urinary matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 biomarkers for predicting renal scar in children with urinary tract infection","volume":"43","author":"Abedi","year":"2017","journal-title":"Turk. J. Urol."},{"key":"10.1016\/j.biopha.2025.118929_bib48","article-title":"Genetic and virulence characteristics of a hybrid atypical enteropathogenic and uropathogenic Escherichia coli (aEPEC\/UPEC) Strain","volume":"10","author":"Valiatti","year":"2020"},{"issue":"4","key":"10.1016\/j.biopha.2025.118929_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s13353-022-00718-8","article-title":"Virulence genes, phylogenetic analysis, and antimicrobial resistance of Escherichia coli isolated from urinary tract infection in hospitalized patients and outpatients","volume":"63","author":"Derakhshan","year":"2022","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.biopha.2025.118929_bib50","article-title":"Multidrug resistance in pathogenic Escherichia coli isolates from urinary tract infections in dogs, Spain","volume":"11","author":"Abad-Fau","year":"2024"},{"issue":"2","key":"10.1016\/j.biopha.2025.118929_bib51","first-page":"407","article-title":"Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection","volume":"52","author":"Toval","year":"2014"},{"issue":"11","key":"10.1016\/j.biopha.2025.118929_bib52","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1128\/JCM.01909-12","article-title":"Enteroaggregative Escherichia coli O78:H10, the cause of an outbreak of urinary tract infection","volume":"50","author":"Olesen","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118929_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1574-695X.2008.00388.x","article-title":"Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli","volume":"52","author":"Abe","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12879-019-3994-3","article-title":"Use of ceragenins as a potential treatment for urinary tract infections","volume":"19","author":"Wnorowska","year":"2019","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118929_bib55","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/jor.24615","article-title":"The application of ceragenins to orthopedic surgery and medicine","volume":"38","author":"Dao","year":"2020","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2672.2010.04874.x","article-title":"Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections","volume":"110","author":"Leszczy\u0144ska","year":"2011","journal-title":"J. Appl. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2025.118929_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-23281-y","article-title":"Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection","volume":"12","author":"Wnorowska","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118929_bib58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dkm457","article-title":"Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa","volume":"61","author":"Chin","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118929_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/710273","article-title":"Potential synergy activity of the novel ceragenin, CSA-13, against carbapenem-resistant Acinetobacter baumannii strains isolated from bacteremia patients","volume":"2014","author":"Bozkurt-Guzel","year":"2014","journal-title":"Biomed. Res Int"},{"issue":"2","key":"10.1016\/j.biopha.2025.118929_bib60","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.21160","article-title":"Pathophysiology of enteropathogenic Escherichia coli during a host infection","volume":"23","author":"Lee","year":"2022","journal-title":"J. Vet. Sci."},{"issue":"48","key":"10.1016\/j.biopha.2025.118929_bib61","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v11.i48.7661","article-title":"Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis","volume":"11","author":"Panasiuk","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118929_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.735","article-title":"Serum bile acids in liver cirrhosis promote neutrophil dysfunction","volume":"12","author":"Balazs","year":"2022","journal-title":"Clin. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:53:10Z","timestamp":1773924790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S0753332225011230"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118929","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of ceragenin CSA-13 in acute pyelonephritis -insights from an animal model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118929"}}